Zhou, X., Tu, S., Wang, C., Huang, R., Deng, L., Song, C., . . . Li, Y. (2020). Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas. Front Immunol.
استشهاد بنمط شيكاغوZhou, Xuan, et al. "Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas." Front Immunol 2020.
MLA استشهادZhou, Xuan, et al. "Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas." Front Immunol 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.